SCRIB and breast carcinoma: SCRIB Pro 305 Leu mutant (SCRIB P305L), which fails to locate plasma membrane, promotes cell proliferation in mammary epithelial cells in vivo9, and downregulation of SCRIB attenuates the tumor-growth ability in ER-negative (ER−) breast cancer cells9.